| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7305effc496dec13622f0c922f5578db |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2017-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_75c64b418722627ac4ca538706792b1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cc0c168143183287a982e2f481dd5f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_848af165ffda8dbd00f7c08b18348c85 |
| publicationDate |
2019-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110366424-A |
| titleOfInvention |
Composition in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a copolyamino acid |
| abstract |
The present invention relates to a composition in the form of an injectable aqueous solution having a pH of 6.0 to 8.0 comprising at least: a) amylin, an amylin receptor agonist or an amylin analogue; b) a carboxylate-charged and hydrophobic A copolyamino acid of the group Hy, said copolyamino acid being formed from glutamic acid or aspartic acid units and said hydrophobic group Hy having the following formula I: The composition is characterized in that: the composition does not contain basal insulin whose isoelectric point pi is 5.8 to 8.5. The invention also relates to a composition characterized in that it also comprises prandial insulin. |
| priorityDate |
2016-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |